QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CRVS

QT64Corvus Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
11.91
-0.09-0.75%
OverviewShort InterestFilings
CRVSQT64Corvus Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
11.91-0.75%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 15, 2026Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 2026Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 2026Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 2026Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 2026Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 2026Jun 12, 20268-KCurrent report
May 20, 2026May 20, 20264Statement of changes in beneficial ownership
May 15, 2026May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 14, 2026May 14, 20268-KCurrent report
May 07, 2026May 07, 2026S-8Registration of employee benefit securities
May 07, 2026May 07, 202610-QQuarterly report
May 07, 2026May 07, 20268-KCurrent report
Apr 27, 2026Apr 27, 20263Initial statement of beneficial ownership
Apr 27, 2026Apr 27, 2026SC 13G/ASC 13G/A
Apr 27, 2026Apr 27, 20264Statement of changes in beneficial ownership
Apr 24, 2026Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 2026Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026Apr 23, 20268-KCurrent report
Mar 26, 2026Mar 26, 2026SC 13G/ASC 13G/A
Mar 13, 2026Mar 13, 2026424B5424B5
Mar 13, 2026Mar 13, 2026S-3ASRS-3ASR
Mar 13, 2026Mar 13, 20268-KCurrent report
Mar 12, 2026Mar 12, 202610-KAnnual report
Mar 12, 2026Mar 12, 20268-KCurrent report
#1 / 25 of 231
Page
▼
/ 10